Bradykinin antagonists: Present progress and future prospects. J.M. Stewart, L. Gera, E.J. York, D.C. Chan and P. Bunn. Immunopharmacology 43: 155-161, 1999.
Novel bradykinin antagonist dimers for the treatment of human lung cancers. D. Chan, L. Gera, B. Helfrich, K. Helm, J. Stewart, E. Whalley and P. Bunn. Immunopharmacology 33: 201-204, 1996.
Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications. J.M. Stewart, L. Gera, D.C. Chan, E.T. Whalley, W.L. Hanson and J.S. Zuzack. Immunopharmacology 36: 167-172, 1997.
NMR and CD conformational studies of bradykinin and its agonists and antagonists: Application to receptor binding. G. Kotovych, J.R. Cann, J.M.Stewart and H. Yamamoto. Biochem. Cell Biol. 76: 257-266, 1998.
Neuropeptide processing in pathophysiology. J.M. Stewart and M.E. Hall. Agents and Actions 42S: 211-226, 1993.
Studies on chymotrypsin-like catalysis by synthetic peptides. M.J. Corey,. Hallakova, K. Pugh and J.M. Stewart. App. Biochem. Biotechnol., 47:199-212, 1994.
Helix propensities of basic amino acids increase with the length of the side-chain. S. Padmanabhan, E.J. York, J.M. Stewart and R.L. Baldwin. J. Mol. Biol. 257: 726-734, 1996.
Pubmed search for Stewart JM